HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES
Clinical trials for HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES explained in plain language.
Never miss a new study
Get alerted when new HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES trials appear
Sign up with your email to follow new studies for HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame deadly immune storm with fewer side effects
Disease control Recruiting nowThis study tests a new treatment for adults with hemophagocytic lymphohistiocytosis (HLH), a rare condition where the immune system attacks the body. The treatment combines a targeted drug (ruxolitinib) with a shorter, milder version of standard therapy to reduce side effects whi…
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES
Phase: PHASE2 • Sponsor: Jerry Lee, MD, MSc, MPhil • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New HLH registry aims to unlock secrets of rare immune disease
Knowledge-focused Recruiting nowThis study collects information from 200 people with hemophagocytic lymphohistiocytosis (HLH), a rare immune condition. Researchers will track how the disease is diagnosed, what treatments are used, and how patients respond over time. The goal is to better understand HLH and impr…
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 17, 2026 06:48 UTC
-
500-Person study aims to crack the code of autoimmune diseases
Knowledge-focused Recruiting nowThis study is creating a new tool to help doctors diagnose and choose treatments for autoimmune diseases. Researchers will analyze blood samples from 500 children with autoimmune conditions and healthy children to find patterns in genes and other molecules. The goal is to make di…
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Researchers hunt for clues to save lymphoma patients with overactive immune system
Knowledge-focused Recruiting nowThis study looks at lymphoma patients who also develop a serious immune condition called HLH. Researchers will collect data from 2,000 participants to see which treatments and factors help patients live longer. The goal is to find better ways to treat this rare complication.
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Researchers launch study to unravel mysterious immune disorder in adults
Knowledge-focused Recruiting nowThis study is for adults with a rare condition called hemophagocytic lymphohistiocytosis (HLH), where the immune system becomes overactive and damages the body. Researchers will track 81 participants to better understand the disease and see how well treatments like steroids and c…
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Massive global registry launches to monitor blood filter in ICU patients
Knowledge-focused Recruiting nowThis study is a large registry that collects data on how a blood-filtering device called CytoSorb is used in real-world intensive care settings. It will include up to 3,000 critically ill patients with conditions like septic shock, severe lung injury, or liver failure. The goal i…
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES
Sponsor: CytoSorbents, Inc • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC